The Effect of Diabetes Duration on the Response to Liraglutide and Glimepiride in Type 2 Diabetes

被引：0
|
作者：
Gabber, Alan
Matthews, David
Holst, Jens
Zinman, Bernard
Jensen, Klaus
Falahati, Ali
Vora, Jiten
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A197 / A197
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes The LEAD (Liraglutide Effect and Action in Diabetes)-2 study
    Nauck, Michael
    Frid, Anders
    Hermansen, Kjeld
    Shah, Nalini S.
    Tankova, Tsvetalina
    Mitha, Ismail H.
    Zdravkovic, Milan
    During, Maria
    Matthews, David R.
    DIABETES CARE, 2009, 32 (01) : 84 - 90
  • [2] Dosage and Duration of Glimepiride Therapy among Patients With Type 2 Diabetes
    Stender, Monika
    Ambery, Philip
    Koro, Carol
    DIABETES, 2012, 61 : A593 - A593
  • [3] Predictors of response to liraglutide in Japanese type 2 diabetes
    Toyoda, Masao
    Yokoyama, Hiroki
    Abe, Katsushige
    Nakamura, Shuji
    Suzuki, Daisuke
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 (03) : 451 - 457
  • [4] Predictors of response to glimepiride in patients with type 2 diabetes mellitus
    Charpentier, G
    Vaur, L
    Halimi, S
    Fleury, F
    Derobert, E
    Grimaldi, A
    Oriol, V
    Etienne, S
    Altman, JJ
    DIABETES & METABOLISM, 2001, 27 (05): : 563 - 571
  • [5] Comparative, Transversal Analysis of Adding Metformin or Glimepiride Therapy to Liraglutide in the Treatment of Type 2 Diabetes
    Courreges, Jean-Pierre
    Thiriet, Catherine M.
    Abbed, Nejma S.
    DIABETES, 2010, 59 : A201 - A201
  • [6] Predictors of Response to Treatment with Liraglutide in Patients with Type 2 Diabetes
    Zografou, Ioanna
    Griva, Theodora
    Papadopoulou, Despina
    Anyfanti, Panagiota
    Nikolaidou, Barbara
    Lazaridis, Antonios
    Sampanis, Christos Sampanis
    DIABETES, 2015, 64 : A651 - A651
  • [7] Disease duration as an indicator of the efficacy of liraglutide in patients with type 2 diabetes mellitus
    Wilbrink, Francis J.
    Mudde, Aart H.
    Mulder, Alexandra H.
    Bhansing, Kavish J.
    JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (04): : 979 - 980
  • [8] Liraglutide in the management of type 2 diabetes
    Wajcberg, Estela
    Amarah, Amatur
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2010, 4 : 279 - 290
  • [9] Liraglutide for type 2 diabetes mellitus
    Kela, Ram
    Khunti, Kamlesh
    Davies, Melanie J.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (07) : 951 - 959
  • [10] Long-term outcomes in patients with type 2 diabetes receiving glimepiride combined with liraglutide or rosiglitazone
    Sullivan, Sean D.
    Alfonso-Cristancho, Rafael
    Conner, Chris
    Hammer, Mette
    Blonde, Lawrence
    CARDIOVASCULAR DIABETOLOGY, 2009, 8
12345